Mowery & Schoenfeld Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$99K Hold
2,320
0.13% 94
2026
Q1
$146K Sell
2,320
-181
-7% -$14.5K 0.22% 71
2025
Q4
$238K Buy
2,501
+181
+8% +$17.7K 0.35% 45
2025
Q3
$227K Sell
2,320
-46
-2% -$4.76K 0.39% 44
2025
Q2
$254K Hold
2,366
0.39% 39
2025
Q1
$239K Sell
2,366
-271
-10% -$27.3K 0.47% 41
2024
Q4
$236K Buy
2,637
+366
+16% +$32.2K 0.46% 40
2024
Q3
$190K Hold
2,271
0.3% 37
2024
Q2
$175K Hold
2,271
0.25% 37
2024
Q1
$156K Hold
2,271
0.3% 37
2023
Q4
$131K Buy
+2,271
New +$121K 0.27% 49

Other funds holding BSX

Mowery & Schoenfeld Wealth Management's BSX Position: Q2 2026 in Review

Mowery & Schoenfeld Wealth Management held its Boston Scientific (BSX) position steady in Q2 2026 at 2,320 shares worth $99K. The position accounts for 0.13% of the portfolio, ranked #94.

Mowery & Schoenfeld Wealth Management first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $254K in Q2 2025. 773 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Mowery & Schoenfeld Wealth Management held 2,320 shares of Boston Scientific worth $99K as of Q2 2026.
  • Mowery & Schoenfeld Wealth Management left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.13% of Mowery & Schoenfeld Wealth Management's portfolio in Q2 2026, its #94 holding.
  • Mowery & Schoenfeld Wealth Management first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Mowery & Schoenfeld Wealth Management's Boston Scientific position peaked at $254K in Q2 2025.
  • 773 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Mowery & Schoenfeld Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.